Matthew J Witry1, Barbara J St Marie2, Brahmendra Reddy Viyyuri3, Paul D Windschitl4. 1. Department of Pharmacy Practice and Science, University of Iowa, Iowa City, Iowa. Electronic address: matthew-witry@uiowa.edu. 2. College of Nursing, University of Iowa, Iowa City, Iowa. 3. Department of Pharmacy Practice and Science, University of Iowa, Iowa City, Iowa. 4. Department of Psychological and Brain Sciences, University of Iowa, Iowa City, Iowa.
Abstract
BACKGROUND: Prescription monitoring programs (PMPs) can provide health care professionals with valuable information. However, few studies have explored providers' decision making for accessing PMPs. AIMS: This study aimed to identify provider characteristics and situational factors most influencing perceived importance of consulting the PMP for patients in a simulated context. DESIGN: The study used a cross-sectional factorial survey. SETTINGS: The survey was administered electronically. PARTICIPANTS/ SUBJECTS: Community pharmacists, advanced practice registered nurses (APRNs), and physicians in Iowa. METHODS: Participants were recruited by mail which included a link to the online survey. The survey consisted of demographic questions, eight randomly generated vignettes, and one ranked item. The vignettes described a hypothetical prescription using eight experimental variables whose levels were randomly varied. Respondents evaluated each vignette for importance to access the PMP. Analyses used linear mixed-effects models in R (Version 3.5.0). RESULTS: A total of 138 responses were available for multilevel analysis. Women, physicians, and APRNs rated it more important to consult the PMP for a given prescription compared with men and pharmacists. Accessing a PMP was perceived as more important with cash payments, quantity dispensed, suspicion for misuse, hydromorphone and oxycodone prescriptions, and headache. Advancing age, postoperative pain, and anxiety or sleep indications were associated with less importance. CONCLUSIONS: Age, indication for prescribing, misuse, and payment mode each independently had greater importance to providers in accessing the PMP. This was the first study to isolate the influence of different controlled substances on how important it was to consult the PMP.
BACKGROUND: Prescription monitoring programs (PMPs) can provide health care professionals with valuable information. However, few studies have explored providers' decision making for accessing PMPs. AIMS: This study aimed to identify provider characteristics and situational factors most influencing perceived importance of consulting the PMP for patients in a simulated context. DESIGN: The study used a cross-sectional factorial survey. SETTINGS: The survey was administered electronically. PARTICIPANTS/ SUBJECTS: Community pharmacists, advanced practice registered nurses (APRNs), and physicians in Iowa. METHODS:Participants were recruited by mail which included a link to the online survey. The survey consisted of demographic questions, eight randomly generated vignettes, and one ranked item. The vignettes described a hypothetical prescription using eight experimental variables whose levels were randomly varied. Respondents evaluated each vignette for importance to access the PMP. Analyses used linear mixed-effects models in R (Version 3.5.0). RESULTS: A total of 138 responses were available for multilevel analysis. Women, physicians, and APRNs rated it more important to consult the PMP for a given prescription compared with men and pharmacists. Accessing a PMP was perceived as more important with cash payments, quantity dispensed, suspicion for misuse, hydromorphone and oxycodone prescriptions, and headache. Advancing age, postoperative pain, and anxiety or sleep indications were associated with less importance. CONCLUSIONS: Age, indication for prescribing, misuse, and payment mode each independently had greater importance to providers in accessing the PMP. This was the first study to isolate the influence of different controlled substances on how important it was to consult the PMP.
Authors: Yama Issa; Usama Ahmed Ali; Stefan A W Bouwense; Hjalmar C van Santvoort; Harry van Goor Journal: Surg Endosc Date: 2013-09-06 Impact factor: 4.584
Authors: Gillian J Leichtling; Jessica M Irvine; Christi Hildebran; Deborah J Cohen; Sara E Hallvik; Richard A Deyo Journal: Pain Med Date: 2017-06-01 Impact factor: 3.750
Authors: Marc L Fleming; Jamie C Barner; Carolyn M Brown; Marv D Shepherd; Scott A Strassels; Suzanne Novak Journal: J Am Pharm Assoc (2003) Date: 2014 May-Jun
Authors: Brent J Morris; Justin W Zumsteg; Kristin R Archer; Brian Cash; Hassan R Mir Journal: J Bone Joint Surg Am Date: 2014-08-06 Impact factor: 5.284
Authors: Sabrina J Poon; Margaret B Greenwood-Ericksen; Rebecca E Gish; Pamela M Neri; Sukhjit S Takhar; Scott G Weiner; Jeremiah D Schuur; Adam B Landman Journal: Acad Emerg Med Date: 2016-03-26 Impact factor: 3.451
Authors: Rebecca L Haffajee; Michelle M Mello; Fang Zhang; Alan M Zaslavsky; Marc R Larochelle; J Frank Wharam Journal: Health Aff (Millwood) Date: 2018-06 Impact factor: 6.301
Authors: Mary Brigid Quirke; Denise Alexander; Kate Masterson; Jo Greene; Cathal Walsh; Piet Leroy; Jay Berry; Lee Polikoff; Maria Brenner Journal: BMC Med Res Methodol Date: 2022-07-21 Impact factor: 4.612